Age and gender differences in the relationship between hepatitis C infection and all stages of Chronic kidney disease

Chronic kidney disease (CKD) is a worldwide health issue with heavy economic burden. Chronic hepatitis C virus (HCV) infection is a common cause of CKD, which can significantly impact the progression and mortality among patients with CKD. The prevalence of both illnesses is high in Taiwan. A multicentre and population‐based cross‐sectional study including 24 642 subjects was conducted to explore the association of HCV infection with the prevalence and severity of CKD. The measurements of metabolic parameters, eGFR and CKD stages were compared between subjects with HCV seropositivity and seronegativity. The analyses of association between HCV infection with CKD stages and evaluation of potential risk factors of CKD were performed by gender and age (≤ and >45 years). HCV‐seropositive subjects accounted for 6.9% and had a significantly older age. The prevalence of CKD increased in those with HCV seropositivity (16.5%). Significantly higher prevalence of CKD stages ≥3 in HCV‐seropositive subjects was noticed (7.8%). Age (>45 year), male gender, alcohol drinking, hypertension, creatinine and HCV infection were the significant factors associated with the presence of CKD. HCV seropositivity was an independent risk factor of developing CKD and associated with an increased risk of having CKD of all stages. The higher prevalence of earlier stage of CKD warrants longitudinal studies with frequent testing on renal function and sufficient duration to determine the changes of eGFR over time. Implementation of effective treatment intervention is also required for these subjects to prevent the progression of CKD to late stages.

[1]  K. Karita,et al.  Combined effect of mitochondrial DNA 5178 C/A polymorphism and alcohol consumption on estimated glomerular filtration rate in male Japanese health check-up examinees: a cross-sectional study , 2013, BMC Nephrology.

[2]  S. Velciov,et al.  Chronic kidney disease and the involvement of estrogen hormones in its pathogenesis and progression. , 2012, Romanian journal of internal medicine = Revue roumaine de medecine interne.

[3]  A. Lonardo,et al.  Metabolic alterations and chronic hepatitis C: treatment strategies , 2011, Expert opinion on pharmacotherapy.

[4]  C. Lewis,et al.  Race differences in prevalence of chronic kidney disease among young adults using creatinine-based glomerular filtration rate-estimating equations. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  M. Tonelli,et al.  Population based screening for chronic kidney disease: cost effectiveness study , 2010, BMJ : British Medical Journal.

[6]  Sheng-Nan Lu,et al.  Association of hepatitis C and B virus infection with CKD in an endemic area in Taiwan: a cross-sectional study. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  J. Toffaletti Improving the Clinical Value of Estimating Glomerular Filtration Rate by Reporting All Values: A Contrarian Viewpoint , 2010, Nephron Clinical Practice.

[8]  V. Balan,et al.  Increased Prevalence of Reduced Estimated Glomerular Filtration Rate in Chronic Hepatitis C Patients , 2010, Digestive Diseases and Sciences.

[9]  J. Heathcote,et al.  Hepatitis C and diabetes: one treatment for two diseases? , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[10]  Desmond E. Williams,et al.  A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  N. Powe,et al.  Public health surveillance of CKD: principles, steps, and challenges. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  C. Winearls,et al.  Screening for CKD with eGFR: doubts and dangers. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[13]  Hui Ting Chan,et al.  All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan , 2008, The Lancet.

[14]  L. Rostaing,et al.  Hepatitis C virus-related kidney disease: an overview. , 2008, Clinical nephrology.

[15]  S. Fisher,et al.  Chronic kidney disease prevalence and rate of diagnosis. , 2007, The American journal of medicine.

[16]  E. Vittinghoff,et al.  Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease. , 2007, Archives of internal medicine.

[17]  J. Guh,et al.  Herbal therapy is associated with the risk of CKD in adults not using analgesics in Taiwan. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  Sheng-Nan Lu,et al.  Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV‐endemic areas in an HBV‐endemic country: Geographic variations among 502 villages in southern Taiwan , 2007, Journal of gastroenterology and hepatology.

[19]  Chih-Cheng Hsu,et al.  High prevalence and low awareness of CKD in Taiwan: a study on the relationship between serum creatinine and awareness from a nationally representative survey. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  Song-min Huang,et al.  Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. , 2006, Journal of the American Society of Nephrology : JASN.

[21]  C. Dai,et al.  Viral hepatitis and proteinuria in an area endemic for hepatitis B and C infections: another chain of link? , 2006, Journal of internal medicine.

[22]  R. Klein,et al.  The association among smoking, heavy drinking, and chronic kidney disease. , 2006, American journal of epidemiology.

[23]  V. Howard,et al.  Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study. , 2006, Journal of the American Society of Nephrology : JASN.

[24]  M. Pletcher,et al.  Hepatitis C and hospital outcomes in patients admitted with alcohol-related problems. , 2006, Journal of hepatology.

[25]  J. Buring,et al.  Alcohol consumption and the risk of renal dysfunction in apparently healthy men. , 2005, Archives of internal medicine.

[26]  R. Nelson,et al.  Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. , 2005, Journal of the American Society of Nephrology : JASN.

[27]  K. Lai,et al.  Chronic viral hepatitis in hemodialysis patients , 2005, Hemodialysis international. International Symposium on Home Hemodialysis.

[28]  T. Greene,et al.  Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. , 2005, Journal of the American Society of Nephrology : JASN.

[29]  F. Fabrizi,et al.  Meta‐analysis: effect of hepatitis C virus infection on mortality in dialysis , 2004, Alimentary pharmacology & therapeutics.

[30]  F. Bianchi,et al.  Sirolimus eluting stent aborted recurrent distal left main in-stent restenosis involving bifurcation , 2004, Heart.

[31]  D. Johnson,et al.  Evidence‐based guide to slowing the progression of early renal insufficiency , 2004, Internal medicine journal.

[32]  D. Sandler,et al.  Lifestyle risk factors and chronic kidney disease. , 2003, Annals of epidemiology.

[33]  J. Hoofnagle,et al.  Hepatitis C and renal disease: an update. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[34]  Ajay K. Singh,et al.  A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease. , 2003, Journal of the American Society of Nephrology : JASN.

[35]  M. Ikeda,et al.  Impact of menopause on lipid and bone metabolism and effect of hormone replacement therapy. , 2003, The Tokai journal of experimental and clinical medicine.

[36]  T. Yoshikawa,et al.  Hepatitis C virus and atherosclerosis in patients with type 2 diabetes , 2003 .

[37]  J. Hoofnagle Course and outcome of hepatitis C , 2002, Hepatology.

[38]  Keith C. Norris,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[39]  F. Kronenberg,et al.  Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels. , 2002, Journal of the American Society of Nephrology : JASN.

[40]  S. Pol,et al.  HCV infection and hemodialysis. , 2002, Seminars in nephrology.

[41]  R. Nagai,et al.  Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening , 2002, The Lancet.

[42]  S. Kashiwagi,et al.  Liver Damage in Hemodialysis Patients with Hepatitis C Virus Viremia: A Prospective 10-Year Study , 2000, Digestive Diseases and Sciences.

[43]  R. Carithers Hepatitis C and renal failure. , 1999, The American journal of medicine.

[44]  P. Whelton,et al.  Risk of end-stage renal disease associated with alcohol consumption. , 1999, American journal of epidemiology.

[45]  C. Pomeroy,et al.  Renal manifestations of hepatitis C infection. , 1999, The American journal of medicine.

[46]  F. Dumler,et al.  Gynecologic and reproductive issues in women on dialysis. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[47]  S. Moe,et al.  ORIGINAL INVESTIGATIONS Pathogenesis and Treatment of Kidney Disease Association of Hepatitis C Virus Infection With Prevalence and Development of Kidney Disease , 2008 .

[48]  N. Chalasani,et al.  Relationship between hepatitis C and microalbuminuria: results from the NHANES III. , 2005, Kidney international.